approval to build upon its open-label Phase II trial of RECCE ® 327 Topical Gel (R327G) for the treatment of diabetic foot infections (DFI), enabling the enrollment of up to 20 additional patients.

In November 2022, Virginia-based Contraline became the first company to ever implant a male contraceptive gel into humans in a clinical trial. By now, the gel has been implanted into the vas ...

An implantable, non-hormonal male contraceptive has been shown in trials to last for at least two years. The contraceptive, known as Adam, is a water-soluble hydrogel that is implanted in the sperm ...

Today I'm comparing the best-selling foam, gel, and air-filled seat cushions to see how they stack up. These were the best-selling cushions of their types on Amazon as of January 2022. Senator ...

SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), a leading developer of a new class of synthetic anti-infectives, today announced it ...

Here’s how it works. The best OBD-II scanners can unlock the secrets of your car, connecting to the onboard computer and giving you access to the information it contains. Whether there's a ...

ASICS is giving fans one last chance to grab the ever-popular ASICS GEL-KAYANO 30 running shoe at a discount before it disappears for good. With the release of the new GEL-KAYANO 31 in June ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.